Cluster randomized trial in Veterans Affairs hospitals shows a tailored quality intervention multiplies sleep apnea testing ...

Bristol Myers Squibb and Johnson & Johnson to discontinue phase 3 Librexia ACS trial of milvexian treat acute coronary syndrome: Princeton, New Jersey Monday, November 17, 2025, 1 ...

Prompt, intensive blood pressure lowering within days of a TIA or minor stroke cuts recurrent stroke rates, results of a ...

The Librexia clinical trial program includes two other Phase 3 trials, Librexia AF for patients with atrial fibrillation (AF) and Librexia STROKE for secondary stroke prevention (SSP). The IDMC ...

Patients receiving oral niacinamide for nonmelanoma skin cancer chemoprophylaxis show fewer cardiac events, a retrospective ...

Results from the international VESALIUS-CV (TIMI 66) clinical trial found that among adults with atherosclerotic cardiovascular disease (ASCVD) or diabetes and no history of a prior heart attack or ...

Dr Chawla warns that stroke occur suddenly and explains how to recognise the warning signs, also known as Transient Ischemic ...

India faces a silent stroke crisis with rising cases among young adults. Dr Tarun Mathur, Senior Consultant – Neurology, ...

Mortality/major ischemic events at 90 days were no lower than with a restrictive strategy—but cardiac complications differed.

A dizzy moment. A slurred word. A smile that doesn't lift right. While many brush these off, they can be your brain's SOS.

Results from the international VESALIUS-CV (TIMI 66) clinical trial found that among adults with atherosclerotic ...

Of note, the iMODERN trial had also excluded people with a history of prior STEMI, chronic total occlusion, complex non-culprit lesions, left main disease, and those hemodynamically unstable or left ...